1977
DOI: 10.1038/268068a0
|View full text |Cite
|
Sign up to set email alerts
|

Immunological tolerance and tumour allografts in the brain

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
10
0

Year Published

1977
1977
2023
2023

Publication Types

Select...
7
1
1

Relationship

1
8

Authors

Journals

citations
Cited by 30 publications
(10 citation statements)
references
References 5 publications
0
10
0
Order By: Relevance
“…Although the initial experiments carried out by Medawar and colleagues (1), as well as others (2), have demonstrated that the immune response to the central nervous system (CNS) antigens does exist (although it is distinct from the response in other tissues), the CNS was traditionally viewed as an immune-privileged site. This depiction set a clear separation between the nervous and immune systems until quite recently (3, 4).…”
mentioning
confidence: 99%
“…Although the initial experiments carried out by Medawar and colleagues (1), as well as others (2), have demonstrated that the immune response to the central nervous system (CNS) antigens does exist (although it is distinct from the response in other tissues), the CNS was traditionally viewed as an immune-privileged site. This depiction set a clear separation between the nervous and immune systems until quite recently (3, 4).…”
mentioning
confidence: 99%
“…A better prognosis was achieved by applying an anti-in ammatory drug combination than by using an antiparasitic drug alone [35]. The central nervous system was previously considered to be an immune-privileged area because the blood-brain barrier blocks immune cells and cytokines from entering the brain [36]. However, recent studies have demonstrated that the nervous system also has inherent and adaptive immunity, particularly since rich lymphatic vessels have been found in the sinus durae matris [37].…”
Section: Discussionmentioning
confidence: 99%
“…Similar data were obtained by Scheinberg et al [66] when using a methylcholanthrene-induced mouse ependymoblastoma which was capable of eliciting first set rejections when transplanted intracerebrally into allogeneic hosts and a second set rejection of tumor cell implants in syngeneic hosts. The presence of specific immunity following inoculation of RSL sarcoma cells into the rat brain was demonstrated recently by Hasek et al [25]. In a transplantable tumor model in which the human glioma tumor cell line D-54 MG was grown in Fischer rats, it was found that intracerebral growth of the tumor cells and survival of the animals was dependent on concomitant immunosuppression.…”
Section: Intracerebral Antigens Escape From Immune Recognitionmentioning
confidence: 90%